Measurements of weight, blood pressure, and total cholesterol (Table 2 ) showed a trend toward improvement from baseline through 48 weeks that were greater following period 2 with ACTIVE treatment as compared to CONTROL treatment but these were not significant due to the small numbers of patients in each cohort and the large variability within each cohort.
← all excerpts
Gastric electrical stimulation treatment of type 2 diabetes: effects of implantation versus meal-mediated stimulation. A randomized blinded cross-over trial.
1
—
—